In part one of this two-part series, Dr. Stacey Clardy and Dr. Elia Sechi discuss the clinical scenarios where the commonly used assay for myasthenia gravis is most likely to produce false positive results in patients who do not actually have myasthenia gravis.

Show reference: https://www.neurology.org/doi/10.1212/WNL.0000000000213498  

Dr. Roy E. Strowd and Dr. Susannah Cornes discuss a teaching incentive initiative designed to support and reward faculty in academic neurology. 

Show reference:

https://www.neurology.org/doi/10.1212/NE9.0000000000200182 

In the first installment of this three-part series, Dr. Elizabeth Zollos explores how optical coherence tomography is advancing our understanding of multiple sclerosis and enhancing diagnostic accuracy. 

In part two of this two-part series, Dr. Jeff Ratliff and Dr. Per Borghammer explore the subcategories of Lewy body disease, focusing on the body-first subtype

Show reference:

https://www.nature.com/articles/s41593-025-01910-9 

In the second installment of this two-part series, Dr. Stacey Clardy and Dr. Janis Miyasaki discuss how she got involved with the AAN. 

Show reference: 

https://www.aan.com/news/aan-honors-leader-volunteer-2025-presidents-award  

In part one of this two-part series, Dr. Jeff Ratliff and Dr. Per Borghammer examine the dichotomy that existed before his team began this project.

Show reference:

https://www.nature.com/articles/s41593-025-01910-9 

In the first installment of this two-part series, Dr. Stacey Clardy engages in a thought-provoking conversation with Dr. Janis Miyasaki, asking her to share two invaluable pieces of wisdom.

Show reference: 

https://www.aan.com/news/aan-honors-leader-volunteer-2025-presidents-award 

Dr. Jeff Lambe talks about progressive multiple sclerosis. 

Show references:

https://journals.lww.com/co-neurology/abstract/2025/06000/re_defining_progression_in_multiple_sclerosis.4.aspx 

https://www.thelancet.com/journals/laneur/article/PIIS1474-4422(23)00281-8/abstract 

https://www.thelancet.com/journals/laneur/article/PIIS1474-4422(14)70256-X/abstract 

https://www.tandfonline.com/doi/full/10.1080/14737175.2022.2143265 

https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0288967 

https://jamanetwork.com/journals/jamaneurology/article-abstract/2809772 

https://www.nejm.org/doi/full/10.1056/NEJMoa2415988 

Dr. Justin Abbatemarco discuss autoimmune encephalitis with a focus on outcomes. 

Show reference: 

https://www.neurology.org/doi/10.1212/WNL.0000000000210109 

https://www.thelancet.com/journals/laneur/article/PIIS1474-4422(23)00463-5/abstract 

In part two of this two-part series, Dr. Dan Ackerman and Dr. Trey Bateman discuss handling patient requests for blood-based biomarkers for Alzheimer disease and interpreting test results.